Skip to content

A study to compare efficay of Inj. Phenylephrine versus Inj. Noradrenaline for treating low blood pressure during caesarean section.

Comparative evaluation of intravenous bolus of Phenylephrine Versus intravenous bolus of Noradrenaline for treatment of hypotension in patients undergoing elective caesarean section under spinal anaesthesia.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027551
Enrollment
100
Registered
2020-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Inj Phenylephrine: Bolus dose of 50 mcg Inj.Phenylephrine repeated every 15 minutes till the correction of hypotension in caesarean section patients under spinal anaesthesia. Control In

Sponsors

Dr Divakar S R
Lead Sponsor
Dr Kiran A V
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Undergoing elective LSCS under spinal anaesthesia Singleton pregnancy at term Uncomplicated pregnancy American Society of Anaesthesia physical status ( ASA) I and II Age group 20 to 30 years Weight 50 to 70 kg Height more than 150 cm

Exclusion criteria

Exclusion criteria: Foetal abnormalities Allergy to Inj. Noradrenaline or Inj. Phenylephrine

Design outcomes

Primary

MeasureTime frame
To compare the average number of bolus doses of Norepinephrine or Phenylephrine required to treat spinal hypotension. To compare average total dose of Norepinephrine or Phenylephrine required to treat spinal hypotension. Timepoint: 1 year

Secondary

MeasureTime frame
To compare the occurence of bradycardia, hypertension, nausea and vomiting in mother and foetal outcomes among the two groups.Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Divakar S R

Mandya institute of medical sciences

drdivakar83@gmail.com9008602855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026